Sanofi targets high single digit sales growth in 2026, plans share buyback Published 29 Jan, 2026 12:50pm In 2025, Sanofi completed a 5 billion euro share buyback program
Drugmakers brace for Europe pricing fight after Trump’s US price-cut deals Updated 09 Jan, 2026 08:17am Global drugmakers face a battle in 2026 to secure higher prices for their prescription medicines in Europe after...
Drugmakers raise US prices on 350 medicines despite pressure from Trump Published 01 Jan, 2026 07:36am Drugmakers plan to raise US prices on at least 350 branded medications including vaccines against COVID, RSV and...
Sanofi’s quarterly profit boosted by Dupixent and newer drugs, forecast unchanged Published 24 Oct, 2025 11:24am LONDON: France’s Sanofi reported a third-quarter profit that beat analysts’ expectations on Friday, boosted by...
EU stages antitrust raids in vaccines co Published 01 Oct, 2025 07:27am PARIS: French pharmaceutical group Sanofi announced on Tuesday that it is being investigated by the EU as part of a...
Sanofi revises annual sales growth expectations on strong Dupixent demand Published 31 Jul, 2025 10:57am France’s Sanofi said on Thursday that it expects annual sales to grow by high single-digit percentage, helped by...
Sanofi to buy US biopharma group Blueprint for over $9 billion Published 02 Jun, 2025 12:43pm PARIS: France’s Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for over $9 billion to boost its...
Sanofi to invest at least $20 billion in the US through 2030 Published 14 May, 2025 09:39pm French drugmaker Sanofi said on Wednesday it plans to invest at least $20 billion in the United States through 2030,...
Sanofi meets estimates for fourth-quarter profit, plans 5 billion euros in buybacks Published 30 Jan, 2025 11:43am French drugmaker Sanofi reported a fourth-quarter profit that came in-line with analysts’ estimates on Thursday, and...
Drugmakers to raise US prices on over 250 medicines starting Jan 1 Published 01 Jan, 2025 03:03am NEW YORK: Drugmakers plan to raise US prices on at least 250 branded medications including Pfizer COVID-19 treatment...
Sanofi MS drug tolebrutinib misses goal in relapsing disease trials Published 02 Sep, 2024 12:36pm Sanofi’s most advanced multiple sclerosis (MS) drug candidate has missed the main goal of two late-stage trials to...
France’s Sanofi in COVID-19 vaccine deal with Novavax Published 10 May, 2024 01:28pm PARIS: Sanofi on Friday announced it has reached a licensing agreement with Novavax to sell a stand-alone COVID-19...
Sanofi profit slips on generic competition and currency effects Published 25 Apr, 2024 01:28pm Sanofi’s first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple...
French shares lag European peers on Sanofi’s dour forecast Published 28 Oct, 2023 05:58am PARIS: European shares fell to near seven-month lows on Friday and clocked a second week of losses, with France’s...
Sanofi: considering consumer unit listing from late next year Published 27 Oct, 2023 10:57am French drugmaker Sanofi said on Friday it was looking into the separate listing of its Consumer Healthcare business...
Sanofi says arbitration court rejects Boehringer’s Zantac claims Published 20 Jun, 2023 12:10pm FRANKFURT: Sanofi said on Tuesday that the International Chamber of Commerce ruled in its favour in an arbitration...
Sanofi Q1 profit buoyed by better-than-expected Dupixent sales Published 27 Apr, 2023 11:26am French drugmaker Sanofi on Thursday posted better-than-expected earnings for the first quarter as continued gains...
Sanofi hones in on type 1 diabetes in $2.9bn Provention Bio deal Published 13 Mar, 2023 02:11pm France’s Sanofi has agreed to acquire Provention Bio for $2.9 billion to bolster its work on type 1 diabetes therapy...
Judge to weigh key evidence ahead of first Zantac cancer trial Published 17 Feb, 2023 11:26am GSK Plc is expected to urge a California judge on Thursday to limit what expert testimony jurors can hear in the...
Makers to raise drug prices in US this month Published 01 Jan, 2023 03:14am Drugmakers including Pfizer Inc, GlaxoSmithKline PLC, Bristol Myers Squibb , AstraZeneca PLC and Sanofi SA plan to...
Sanofi trial failure halts work on breast cancer treatment amcenestrant Published 17 Aug, 2022 10:41pm Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial potential in breast...
GSK, Sanofi and Haleon shares slump on Zantac litigation concerns Published 12 Aug, 2022 12:35am LONDON: Shares in GSK, Sanofi and Haleon fell sharply on Thursday, following declines earlier this week, amid ...
Sanofi, GSK COVID vaccine found effective against Omicron Published 24 Jun, 2022 01:38pm PARIS: Late-stage data on an experimental COVID-19 vaccine from Sanofi and GSK has showed the shot confers...
Sanofi-GSK Covid booster jab shows positive results Published 13 Jun, 2022 06:29pm PARIS: French drug maker Sanofi said Monday a Covid booster shot it is developing with Britain’s GlaxoSmithKline has...
Healthcare companies Sanofi and GSK to seek COVID-19 vaccine regulatory approval Published 23 Feb, 2022 03:39pm PARIS: Healthcare companies Sanofi and GSK said they intend to submit data from both their booster and Phase III...
Sanofi sees strong earnings Published 07 Feb, 2022 05:22am PARIS: French pharmaceutical group Sanofi posted strong 2021 sales on Friday and expects another good performance in...
France's Sanofi eyes COVID-19 shot approval helping grow 2022 earnings Published 04 Feb, 2022 02:48pm PARIS: French drugmaker Sanofi said it still expected its COVID-19 vaccine to win approval in the first quarter and...
Healthcare group Sanofi forms research deal with the company Exscientia Published 07 Jan, 2022 11:34am PARIS: French healthcare company Sanofi , which has been under pressure to revive its drug pipeline after some...
Purchase of up to 52.87pc Sanofi-Aventis shares: Arif Habib Ltd submits public announcement of intention Published 28 Dec, 2021 03:54am KARACHI: Arif Habib Limited has submitted public announcement of intention to acquire up to 52.87 percent shares of...
Sanofi to buy US biotech firm Amunix for $1bn Published 21 Dec, 2021 12:47pm PARIS: French pharma giant Sanofi said Tuesday it had signed a billion-dollar deal to buy US-based biotech firm...